Afuco™ Anti-Neutrokine alpha ADCC Therapeutic Antibody, ADCC Enhanced

Anti-Neutrokine alpha ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibody binds to neutrokine-alpha which is a novel member of the TNF ligand superfamily, and is used as a treatment drug for lupus.
Supplier Creative Biolabs
Product # AFC-755CL
Pricing Inquiry
Type ADCC enhanced antibody
Storage 4 °C, -20°C if preferred
Target Neutrokine alpha
Feedback